FC Stock News
Wednesday, February 21, 2007
FDA Refuses Pharmacyclics Application
Shares of Pharmacyclics Inc. (PCYC) plunged after the FDA refused to accept the company's application for its lung cancer treatment Xcytrin. The stock price plummeted $1.85 to close at $3.19.
posted by FC Market News at
9:07 AM
0 Comments:
Post a Comment
<< Home
About Me
Name:
FC Market News
View my complete profile
Previous Posts
Earnings Rise For Medco
Chemed's Earnings Quadruple
Vasco Beats Expectations
Failed Trial For BioMarin
Sirius And XM Satellite To Merge
Empire Resorts Receives Approval
Vulcan Bids On Florida Rock
Scotts Miracle-Gro Declares Dividend
Revenue Falls Short For Captaris
Campbell Reports Higher Earnings
0 Comments:
Post a Comment
<< Home